Showing results (1211-1220 of 7,002) with videos related to
Sort By:
Pageof 701
Current Medical Research and Opinion|July 4, 2007
International Society for Medical Publication Professionals (ISMPP) position statement: the role of the professional medical writerRobert Norris, Aly Bowman, Jean M Fagan, et al.Current Medical Research and Opinion|September 19, 2007
Injection therapy for the treatment of erectile dysfunction: a comparison between alprostadil and a combination of vasoactive intestinal polypeptide and phentolamine mesilateP J R Shah, W Dinsmore, R A Oakes, et al.Current Medical Research and Opinion|September 12, 2007
Reviewing CATIE for clinicians: balancing benefit and risk using evidence-based medicine toolsJamie Karagianis, Michael Rosenbluth, Mauricio Tohen, et al.Current Medical Research and Opinion|September 18, 2007
Long dosing intervals in the treatment of postmenopausal osteoporosisE Michael LewieckiCurrent Medical Research and Opinion|June 20, 2008
Tegaserod in patients with mechanical sensitivity and overlapping symptoms of functional heartburn and functional dyspepsiaPhilip B Miner, Sheila Rodriguez-Stanley, Howard M Proskin, et al.Current Medical Research and Opinion|March 5, 2009
Neuromuscular blockade, reversal agent use, and operating room time: retrospective analysis of US inpatient surgeriesBin Zhang, David L Hepner, Mary Helen Tran, et al.Current Medical Research and Opinion|March 7, 2009
Standardized arrangement for a guideline-driven treatment of the metabolic syndrome: the SAGE-METS studyV G Athyros, A Karagiannis, A I Hatzitolios, et al.Current Medical Research and Opinion|March 12, 2009
Treatment of patients with primary open-angle glaucoma with a fixed combination of brimonidine 0.2%/timolol 0.5%: multicenter, open-label, observational study in GermanyUlrich Thelen, Patricia Buchholz, Friedemann KimmichCurrent Medical Research and Opinion|February 28, 2009
Antihypertensive efficacy and tolerability of aliskiren/hydrochlorothiazide (HCT) single-pill combinations in patients who are non-responsive to HCT 25 mg aloneMatthias Blumenstein, Jerzy Romaszko, Alberto Calderón, et al.Current Medical Research and Opinion|March 4, 2009
Effectiveness and safety of recombinant human erythropoietin beta in maintaining common haemoglobin targets in routine clinical practice in Europe: the GAIN studyThomas Rath, Robert A Mactier, Thomas Weinreich, et al.Pageof 701